RT STAT3 DanaFarber Moffitt Cancer We seek partners or equity investors. As a matter of fact we anticipate IPO in the 2nd quarter. be treated through STAT3 inhibitionLet me also mention the coupled diagnostics which could be a greater revenue driv

RT #STAT3 #DanaFarber #Moffitt #Cancer We seek partners or equity investors. As a matter of fact, we anticipate IPO in the 2nd quarter. be treated through STAT3 inhibition Let me also mention the coupled diagnostics which could be a greater revenue driv

RT #STAT3 #DanaFarber #Moffitt #Cancer We seek partners or equity investors. As a matter of fact, we anticipate IPO in the 2nd quarter. be treated through STAT3 inhibition Let me also mention the coupled diagnostics which could be a greater revenue driver than the therapeutics pic.twitter.com/evc313FAjy

More From BioPortfolio on "RT #STAT3 #DanaFarber #Moffitt #Cancer We seek partners or equity investors. As a matter of fact, we anticipate IPO in the 2nd quarter. be treated through STAT3 inhibition Let me also mention the coupled diagnostics which could be a greater revenue driv"